BRIM Biotechnology Inc.   Report issue

For profit Phase 3
Founded: Taipei Taiwan (2013)

Organization Overview

First Clinical Trial
2017
NCT03066219
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

BRIM Biotechnology Inc.